Stockholm - Delayed Quote SEK

Acarix AB (publ) (ACARIX.ST)

Compare

0.3240

-0.0035

(-1.07%)

At close: October 25 at 5:29 PM GMT+2

Currency in SEK All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

6,255.0000

6,241.0000

5,822.0000

3,760.0000

2,170.0000

Cost of Revenue

734.0000

944.0000

1,201.0000

937.0000

576.0000

Gross Profit

5,522.0000

5,298.0000

4,621.0000

2,823.0000

1,594.0000

Operating Expense

76,250.0000

82,850.0000

81,096.0000

54,519.0000

43,025.0000

Operating Income

-70,728.0000

-77,552.0000

-76,475.0000

-51,696.0000

-41,431.0000

Net Non Operating Interest Income Expense

-32.0000

-101.0000

-149.0000

-35.0000

-52.0000

Pretax Income

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Net Income Common Stockholders

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Diluted NI Available to Com Stockholders

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Basic EPS

-0.10

-0.16

-0.31

-0.33

-0.42

Diluted EPS

-0.10

-0.16

-0.31

-0.33

-0.42

Basic Average Shares

680,406.0000

475,131.0000

251,972.0000

156,234.4610

98,501.4430

Diluted Average Shares

680,406.0000

475,131.0000

262,085.0000

166,473.9690

98,501.4430

Total Operating Income as Reported

-70,730.0000

-77,553.0000

-76,475.0000

-51,696.0000

-41,431.0000

Total Expenses

76,984.0000

83,794.0000

82,297.0000

55,456.0000

43,601.0000

Net Income from Continuing & Discontinued Operation

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Normalized Income

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Interest Income

32.0000

31.0000

14.0000

36.0000

Interest Expense

64.0000

132.0000

163.0000

71.0000

52.0000

Net Interest Income

-32.0000

-101.0000

-149.0000

-35.0000

-52.0000

EBIT

-70,882.0000

-77,707.0000

-76,822.0000

-51,660.0000

-41,444.0000

EBITDA

-67,916.0000

-74,619.0000

-73,785.0000

-48,282.0000

-37,991.0000

Reconciled Cost of Revenue

734.0000

944.0000

1,201.0000

937.0000

576.0000

Reconciled Depreciation

2,966.0000

3,088.0000

3,037.0000

3,378.0000

3,453.0000

Net Income from Continuing Operation Net Minority Interest

-70,946.0000

-77,839.0000

-76,985.0000

-51,731.0000

-41,496.0000

Normalized EBITDA

-67,916.0000

-74,619.0000

-73,785.0000

-48,282.0000

-37,991.0000

12/31/2020 - 12/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

NEOLA.ST Neola Medical AB (publ)

2.4400

-7.58%

6YC.F Senzime AB (publ)

0.5030

+1.11%

SDET.ST SensoDetect Aktiebolag (publ)

0.2240

-8.57%

SCIB.ST SciBase Holding AB (publ)

0.5100

+2.00%

QLIFE.ST Qlife Holding AB (publ)

2.4200

0.00%

QLINEA.ST Q-linea AB (publ)

2.4250

0.00%

XVIVO.ST Xvivo Perfusion AB (publ)

478.50

+0.74%

EMBLA.CO Embla Medical hf

35.00

-0.57%

GETI-B.ST Getinge AB (publ)

198.50

-1.19%

VITR.ST Vitrolife AB (publ)

235.20

-2.65%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Acarix AB (publ) (ACARIX.ST)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers